Advertisement
UK markets closed

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     

  • AIM

    771.53
    +3.42 (+0.45%)
     

  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     

  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     

  • Bitcoin GBP

    50,672.66
    +1,712.61 (+3.50%)
     

  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     

  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     

  • DOW

    38,675.68
    +450.02 (+1.18%)
     

  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     

  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     

  • DAX

    18,001.60
    +105.10 (+0.59%)
     

  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     
MONEY:

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Cannabis Products Global Market Report 2021 Featuring Canopy Growth Corp, Aphria, Aurora Cannabis, Cara Therapeutics and GW Pharmaceuticals

Research and Markets
·5-min read
Company Logo
Company Logo

Global Cannabis Products Market

Global Cannabis Products Market
Global Cannabis Products Market

Dublin, Feb. 16, 2022 (GLOBE NEWSWIRE) -- The "Cannabis Products Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

Major players in the cannabis products market are Canopy Growth Corporation, Aphria Inc., Aurora Cannabis, Cara Therapeutics and GW Pharmaceuticals PLC.

The global cannabis products market is expected to grow from $16.51 billion in 2020 to $18.37 billion in 2021 at a compound annual growth rate (CAGR) of 11.3%. The market is expected to reach $46.19 billion in 2025 at a CAGR of 25.9%.

The cannabis products market consists of sales of cannabis products and related services. Cannabis is a psychoactive drug which is obtained from the cannabis plant of the cannabaceae family. Cannabis can be used for the treatment of various diseases such as chronic pain, cancer pain, depression, anxiety disorders, sleep disturbances and neurological disorders.

The cannabis products market covered in this report is segmented by product type into flower, concentrates, others. It is also segmented by usage into medical, recreational; by compound into THC-dominant, CBD-dominant, balanced THC & CBD and by route of administration into oral solutions and capsules, smoking, vaporizers, topicals, others.

The presence of several legal norms related to the use and possession of cannabis is an important restraint on the cannabis products market. These norms include regulations of the Food and Drug Administration (FDA) as well as rules set up by the government of each state in the USA.

ADVERTISEMENT

The FDA reviews all applications of cannabis products for their safety and effectiveness. Despite having laws allowing cannabis businesses, many states in the USA still do not allow such businesses. For instance, Los Angeles, San Francisco, San Jose and San Diego have laws allowing cannabis businesses, but 80% of California's nearly 500 municipalities do not allow retail marijuana businesses.

Solar cannabis cultivation is an emerging trend in the cannabis products market. As cannabis cultivation requires a large amount of energy for lighting, heating, air-conditioning, and dehumidification systems, cannabis products manufacturing companies are investing in solar cannabis cultivation.

This is mainly a result of legalizing cannabis products in various states of the USA, which is continuously increasing the consumption of energy and leading cannabis manufacturers to opt for solar cannabis cultivation. For instance, Aurora acquired 71 acres of land in Medicine Hat, Alberta, and installed a high-technology hybrid greenhouse cannabis production facility.

The growing applications of cannabis in the medical field is an important driver for the cannabis products market. Cannabis is a drug that comes from Indian hemp plants such as Cannabis sativa and Cannabis indica, with THC (delta-9 tetrahydrocannabinol) being the main active chemical in it. Cannabis has several medical applications in conditions such as nausea and vomiting, glaucoma, epilepsy, asthma.

Hence, many countries have legalized the use of cannabis for medical applications despite it being a psychoactive drug. Medical applications of cannabis include treating cancer, chronic pain, depression, arthritis, diabetes, glaucoma, migraines, epilepsy, AIDS, Alzheimer's disease and Parkinson's disease.

The government of California regulates the safety in manufacturing cannabis under the California Code of Regulations, Title 17 Division 1. It states that every manufacturer of cannabis product should obtain a valid license issued by state cannabis licensing agency.

To obtain an annual license for cannabis manufacturing, the manufacturer should submit the physical address of the manufacturing premises and a written security plan. The security plan should include the security measures to prevent access of unauthorized people into the manufacturing premises and prevention of loss or theft of cannabis and cannabis products. Hence, this is expected to maintain vigil on manufacturing of cannabis in the coming the years.

Key Topics Covered:

1. Executive Summary

2. Cannabis Products Market Characteristics

3. Cannabis Products Market Trends and Strategies

4. Impact Of COVID-19 On Cannabis Products

5. Cannabis Products Market Size and Growth
5.1. Global Cannabis Products Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of the Market
5.1.2. Restraints On the Market
5.2. Global Cannabis Products Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of the Market
5.2.2. Restraints On the Market

6. Cannabis Products Market Segmentation
6.1. Global Cannabis Products Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Flower

  • Concentrates

  • Others

6.2. Global Cannabis Products Market, Segmentation by Usage, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Medical

  • Recreational

6.3. Global Cannabis Products Market, Segmentation by Compound, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • THC-Dominant

  • CBD-Dominant

  • Balanced THC & CBD

6.4. Global Cannabis Products Market, Segmentation by Route of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Oral solutions and capsules

  • Smoking

  • Vaporizers

  • Topicals

  • Others

7. Cannabis Products Market Regional and Country Analysis
7.1. Global Cannabis Products Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Cannabis Products Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Companies Mentioned

  • Canopy Growth Corporation

  • Aphria Inc

  • Aurora Cannabis

  • Cara Therapeutics

  • GW Pharmaceuticals PLC

  • Maricann Group

  • Tilray

  • The Cronos Group

  • Tikun Olam

  • United Cannabis Corporation

  • Medical Marijuana Inc

  • MedReleaf Corporation

  • Insys Therapeutics

  • CanniMed Therapeutics

  • Organigram Holdings

  • ABcann Medicinals

  • Lexaria Corp

  • Cannabis Sativa

  • LivWell Enlightened Health LLC

  • Scotts Miracle-Gro Co

  • Sprott Inc

  • Cannabis Science Inc

  • VIVO Cannabis

  • STENOCARE

  • Terra Tech Corp

  • MedMen

For more information about this report visit https://www.researchandmarkets.com/r/f1xh5u

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900